Objective Functional dyspepsia (FD) is a chronic disorder that is difficult to treat.
Helicobacter pylori may contribute to its pathophysiology. A Cochrane review from 2006 …

Background Prokinetics are a class of pharmacological drugs designed to improve
gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its …

Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting
approximately 7% of individuals in the community, with most patients managed in primary …

Functional dyspepsia is a clinically common functional gastrointestinal disorder with a high
prevalence, high impact and high consumption of medical resources. The microbiota in the …

Objective To provide a comprehensive overview of the efficacy, safety, and tolerability of
antidepressants for pain according to condition. Design Overview of systematic reviews …

Postprandial, or meal-related, symptoms, such as abdominal pain, early satiation, fullness or
bloating, are often reported by patients with disorders of gut-brain interaction, including …

Abstract Background **ang Sha Liu Junzi decoction (XSLJZD) is a famous traditional
Chinese medicinal prescription for the treatment of functional dyspepsia (FD) in spleen …

Objectives Disorders of gut-brain interaction, such as irritable bowel syndrome (IBS) and
functional dyspepsia (FD), frequently overlap, but the impact of this on the natural history is …

Description This expert review summarizes approaches to management of pain in disorders
of gut–brain interaction. This review focuses specifically on approaches to pain that persist if …

Aims We compared diagnostic performance, costs, and association with major adverse
cardiovascular events (MACE) of clinical coronary computed tomography angiography …